| Date | Source | Headline | |
|---|---|---|---|
| 10th Oct 2008 | 12:30 pm | RNS | Positive PhaseIIa trial of oral asthma drug |
| 8th Oct 2008 | 7:00 am | RNS | Interim Results |
| 15th Sep 2008 | 7:00 am | RNS | e-Therapeutics partners with KeyGen Biotechnology |
| 4th Sep 2008 | 4:35 pm | RNS | Directorate Change |
| 21st Jul 2008 | 3:42 pm | RNS | Final Results |
| 6th May 2008 | 7:03 am | RNS | Launch of Consultancy Service |
| 4th Apr 2008 | 2:38 pm | RNS | Director/PDMR Shareholding |
| 5th Feb 2008 | 12:02 pm | RNS | Holding(s) in Company |
| 22nd Jan 2008 | 7:01 am | RNS | ETS2101 preclinical progress |
| 10th Dec 2007 | 11:18 am | RNS | Preclinical Update |
| 3rd Dec 2007 | 4:58 pm | RNS | Director/PDMR Shareholding |
| 28th Nov 2007 | 8:00 am | RNS | First day of dealings on AIM |
Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.
To access our Live RNS you must confirm you are a private investor by using the button below.